BridgeBio Pharma (BBIO) Net Cash Flow (QoQ) (2018 - 2026)
BridgeBio Pharma (BBIO) Net Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 16.45 Bn | 15.51 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 524.75% |
| Dec 31, 2025 | 31.18% |
| Sep 30, 2025 | -150.88% |
| Jun 30, 2025 | 248.30% |
| Mar 31, 2025 | -151.02% |
| Dec 31, 2024 | 294.42% |
| Sep 30, 2024 | -296.68% |
| Jun 30, 2024 | -12.99% |
| Mar 31, 2024 | 163.96% |
| Dec 31, 2023 | -164.87% |
| Sep 30, 2023 | 280.60% |
| Jun 30, 2023 | -706.12% |
| Mar 31, 2023 | 126.45% |
| Dec 31, 2022 | -624.40% |
| Sep 30, 2022 | -86.65% |
| Jun 30, 2022 | 544.04% |
| Mar 31, 2022 | -110.40% |
| Dec 31, 2021 | 207.69% |
| Sep 30, 2021 | -113.77% |
| Jun 30, 2021 | -180.50% |